| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |